Primary Navigation for the CDC Website
CDC en Español
Vaccine Safety
divider
E-Mail Icon E-mail this page
Printer Friendly Icon Printer-friendly version
divider
 Vaccine Safety Basics
bullet Information for Parents
bullet Why It's Important to Monitor Vaccine Safety
bullet How Vaccines Are Tested and Monitored
bullet Common Questions
bullet Vaccine Safety Concerns
bullet History of Vaccine Safety

 Public Health Activities
bullet Vaccine Adverse Event Reporting System (VAERS)
bullet Publications
bullet Gardasil Vaccine Reports
bullet Intussusception after RotaTeq Vaccination
bullet Vaccine Safety Datalink (VSD) Project
bullet Clinical Immunization Safety Assessment (CISA) Network
bullet Brighton Collaboration
bullet Vaccine Technology
bullet Emergency Preparedness
bullet Publications
bullet Scientific Agenda

Vaccine Adverse Event Reporting System (VAERS) Publications

Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; The VAERS team. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990–2003. Vaccine 2008.

Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, Seward JF. Safety of varicella vaccine after licensure in the United States: experience from reports to the Vaccine Adverse Event Reporting System, 1995–2005.* The Journal of Infectious Diseases 2008;197(S2):S170–S177.

DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J; VAERS Team. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 2006;24(6):703–707.

Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and guillain-barre syndrome. Drug Safety 32:4.

Haber P, Patel M, Iskander J, Gargiullo P, Baggs J, Parashar U. Importance of On-time RotaTeq Vaccination and Long-term Active Surveillance: In Reply. Pediatrics 2008; 122:1154.

Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, Cortese M, Braun MM, Belongia EA, Miller E, Ball R, Iskander J, Parashar U; Postlicensure Monitoring of Intussusception After RotaTeq Vaccination in the United States, February 1, 2006, to September 25, 2007 Pediatrics 2008; Volume 121:206-1212.

Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2008; 57(28):779.

Iskander J, Pool V, Zhou W, English-Bullard R; The VAERS Team. Data mining in the US using the Vaccine Adverse Event Reporting System. Drug Safety 2006;29(5):375–384.

Morgan J, Roper MH, Sperling L, Schieber RA, HEffelfinger JD, Casey CG, Miller JW, Santibanez S, Herwaldt B, Hightower P, Moro PL, Hibbs BF, Levine NH, Chapman LE, Iskander J, Lane JM, Wharton M, Mootrey GT, Swerdlow DL. Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States Clinical Infectious Diseases 2008: March 15;46, Supplemented 3:S242-50.

Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM, The VAERS Working Group. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1999-2007. Vaccine 2008.

Pool V, Braun MM, Kelso JM, Mootrey G, Chen RT, Yunginger JW, Jacobson RM, Gargiullo PM; VAERS Team. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.* Pediatrics 2002;110(6):e71.

Swerdlow DL, Roper MH, Morgan J, Schieber RA, Sperling LS, Sniadack MM, Neff L, Miller JW, Curtis CR, Marin ME, Iskander J, Moro P, Hightower P, Levine NH, McCauley M, Heffelfinger J, Damon I, Török TJ, Wharton M, Mast EE, Mootrey GT. Ischemic cardiac events during the Department of Health and Human Services smallpox vaccination program, 2003. Clinical Infectious Disease 2008: March 15;46, Supplemented 3:S234-41.

Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatric Infectious Disease Journal 2004;23(4):287&ndash:294.

Vellozzi C. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009;1:125.

Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT; Vaccine Adverse Event Reporting System Team. Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination.* American Journal of Epidemiology 2001;154(11):1006–1012.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)—United States, 1991–2001. MMWR 2003;52(1):1–24.

*Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.

Page last modified: February 11, 2009
Content source: Immunization Safety Office

  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention
1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
Public Inquiries: 1-800-CDC-INFO (232-4636); 1-888-232-6348 (TTY)
USA.govDHHS Department of Health
and Human Services